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Dietary carbohydrate
restriction: Compelling
theory for further research
To the Editor:
We commend the authors of this study for promoting a novel
approach to type 2 diabetes management [1]. The physiologic
argument for carbohydrate restriction in individuals with insulin
resistance or deﬁciencies in insulin secretion is very compelling.
However, as compelling as their argument may be, we recom-
mend exerting caution and exercising due diligence before
recommending changes to treatment guidelines.
The authors criticized current dietary recommendations for
diabetes management, saying that these recommendations were
developed during a trend of recommending low-fat diets. Low-
fat diets were recommended primarily based on compelling phys-
iologic argumentsdbut more recent evidence from randomized
controlled trials (RCTs) has shown that dietary fat, except for
trans-fat, is not as dangerous to health as was once thought [2,3].
The authors make the assertion that their conclusion is “sufﬁ-
ciently compelling that they feel the burden of proof rests with
those who are opposed.” In support of their conclusion, the au-
thors wrote a narrative review that uses an interesting array of
sources as referencesdincluding a few systematic reviews and
RCTs, but also observational studies, pilot studies, uncontrolled tri-
als, online discussion groups, and popular diet books. We would
consider this nonsystematic review incomplete: There were a
number of systematic reviews and Cochrane reviews on the topic
not included in their article [4–9]. We would argue that there are
gaps in the knowledge needed before recommending carbohy-
drate restriction, including the extent of restriction required to
see beneﬁtsdas the authors themselves laid out, there are multi-
ple deﬁnitions of carbohydrate restriction.
Instead of putting the onus on the opposition to design and
conduct trials that could very well change type 2 diabetes man-
agement, we would take a more cautious approach to say that
they have sufﬁciently compelling information for a hypothesis
that would make very interesting RCTs.
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I thank the Drs. Fenton for comments on our review [1]. Our
point, however, was that in diabetes carbohydrate restriction is a
cautious approach. The Fentons provided no evidence that it is
not. Science does not start from scratch. Diabetes is a disease of car-
bohydrate intolerance. It is intuitive that carbohydrate restriction is
theﬁrst thing totry. It isnotnovel:Hamdyequatedtheoriginal Joslin
diet with the Atkins diet [2]. Some form of carbohydrate restriction
is, in fact, widely used in clinical practice. We are counseling a sys-
tematic approach.Most of the authors of our review have extensive
experience treating patientswith low-carbohydrate dietswith clin-
ical successes over dozens of years, totaling thousands of patients.
Conversely, recommending signiﬁcant amounts of carbohydrate
for people with diabetes, knowing that it will increase blood sugar,
increase triacylglycerols, lower high-density lipoprotein, and in-
crease the need for drugs seems to me to be reckless.
That “low-fat diets were recommended primarily based on
compelling physiologic arguments” is not tenable. Numerous sci-
entiﬁc papers, including those cited by the Fentons, and many
scientiﬁc and popular books, including my own [3], show that
low-fat ideas have been based on very poor science.
Given our limited success with current treatment guidelines,
due diligence is required before continuing these guidelines. I do
not know of any randomized controlled trial (RCT) that contra-
dicts the evidence that we presented. What standard of success
are we supposed to meet?
Our review, although narrative in form, is a systematic review.
Our systemwas to search the literature for papers that, regardless
of arbitrary classiﬁcation, bring out important points. We sought
well-designedstudies thatprovidedclearconclusions. Levelsof ev-
idence, gold standards, and other arbitrary classiﬁcations are un-
known in other sciences; the best experiment is the one that
answers the question at hand. As studies become longer and
include more people, control of key variables is reduced and out-
comes generally become less certain. Different approaches make
a contribution but many systematic reviews, including Cochrane,
take studies at face value, do not analyze experimental design,
show slavish dependence on statistics and consistently confuse
statistical signiﬁcance with clinical or scientiﬁc importance.
An RCTmight be valuable, but those who have been funded for
such trials have had the opportunity to include a low-carb arm.
[3]. Another major limitation of the study was that oral refeeding
was not really early. The patients fasted for several days. The au-
thors provided no information about proteins and calories actu-
ally ingested, but the duration of fasting after the onset of
abdominal pain was 8.3  3.9 d in the “early” group and
10.5  5.1 d in the conventional group. Such delayed feeding
could be deleterious considering the proven efﬁciency of early
nutrition in acute pancreatitis to maintain gut barrier perme-
ability and to prevent bacterial translocation [6,7]. The major
point demonstrated by this study was that the patients were
not hungry during the acute phase of pancreatitis, thus enteral
nutrition should have been initiated as soon as possible (prefer-
ably in the ﬁrst 24–48 h) after pancreatitis onset. Other studies
are needed to be able to reach a conclusion about safety and
feasibility of early oral refeeding in severe acute pancreatitis.
Considering the frequency of acute pancreatitis in the world,
this issue remains a major challenge.
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credibility.
Perhaps what is really bothering the Fentons, as it bothers my
medical students, is the idea that a large part of themedical estab-
lishment has gotten things very wrong. I askmy students: “Do you
think that there has ever been a period in the history of medicine
where the greatmajority of physicians and scientists held to views
that were not only wrong but dangerous and refused to change in
the face of contradictory evidence? Do you think that there has
ever been such a time? If you think so, you must at least consider
the possibility that this is another such time.”
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and severe acute pancreatitis:
A prospective controlled,
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really do without enteral nutrition?
To the Editor:
The recent Nutrition article by XL Zhao et al. entitled “Early
oral refeeding based on hunger in moderate and severe acute
pancreatitis: A prospective controlled, randomized clinical trial”
addressed a very relevant question [1]. Even if the concept of
pancreatic rest has been abandoned in recent years, the feasi-
bility of early oral refeeding in cases of severe pancreatitis re-
mains a very pertinent issue. Nevertheless, we believe that the
authors were not able to establish conclusively the superiority
of early oral refeeding considering the design of the study. First,
the study was inadequate in mixing moderate and severe
pancreatitis because the feasibility and the efﬁcacy of oral
refeeding in moderate acute pancreatitis is well established [2].
Severe pancreatitis represented only 27% of the patients in this
study. On the other hand, the control arm did not correspond
to the gold standard treatment recommended in international
guidelines [3]. Ninety-seven percent of patients were treated
by parenteral nutrition, even though enteral nutrition had previ-
ously proven superior. Two meta-analyses showed that enteral
nutrition decreases infectious and surgical complications and
mortality in comparison to parenteral nutrition [4,5]. Moreover,
the patients in the study received other treatments (antibiotic
prophylaxis, somatostatin analogs), which are not recommended
parenteral nutrition for acute pancreatitis. Cochrane Database Syst Rev
2010;(1):CD002837.
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“Re. ‘Early oral refeeding
based on hunger in moderate
and severe acute pancreatitis: A
prospective controlled, randomized
clinical trial.’ Can we really do
without enteral nutrition?”
Author’s response
To the Editor:
Included in this issue of Nutrition is a letter by Dr. Benoı
ˇ
t
Dupont regarding our recently published paper, “Early oral
